Clinical Trials Browser

NCT02792582 2026-04-17

A Phase II Trial of Intensity-Modulated Proton Therapy for Incompletely Resected Craniopharyngioma and Observation for Craniopharyngioma After Radical Resection

Phase 2 Active not recruiting

160 enrolled

CNS

Brain Neoplasms, Craniopharyngioma

NCT05919264 2026-04-09

FOG-001 in Locally Advanced or Metastatic Solid Tumors

Phase 1/2 Recruiting

595 enrolled

CNSGastrointestinalGenitourinaryGynecologicSarcoma

Craniopharyngioma, Carcinoma, Hepatocellular, Neoplasm Metastasis, Neoplasms, Adenomatous Polyposis Coli, Prostatic Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms, Desmoid Tumors

NCT05233397 2026-04-08

ACTEMRA® for the Treatment of Pediatric Adamantinomatous Craniopharyngioma

Phase 2 Recruiting

38 enrolled

CNS

Craniopharyngioma

NCT05286788 2026-04-08

MEKTOVI® for the Treatment of Pediatric Adamantinomatous Craniopharyngioma

Phase 2 Recruiting

38 enrolled

CNS

Craniopharyngioma

NCT05465174 2026-03-09

PNOC029

Phase 2 Recruiting

57 enrolled

CNS

Craniopharyngioma

NCT03970226 2026-02-17

Tocilizumab in Children With ACP

Phase EARLY_PHASE1 Active not recruiting

9 enrolled

CNS

Craniopharyngioma

NCT00840047 2026-01-20

Methionine PET/CT Studies In Patients With Cancer

Phase 2 Active not recruiting

503 enrolled

CNSLymphoidSarcoma

Craniopharyngioma, Ependymoma, Hodgkin Disease, Lymphoma, Non-Hodgkin, Medulloblastoma, Neuroblastoma, Rhabdomyosarcoma, Sarcoma, Ewing, Osteosarcoma

NCT07316101 2026-01-05

Clinical Trial of an Anti-Fog Drainage Device for Endoscopic Endonasal Sellar Region Tumor Surgery

Phase NA Not yet recruiting

20 enrolled

CNSEndocrine

Craniopharyngioma, Pituitary Neoplasms

NCT06970145 2025-11-18

Safety and Efficacy of Anlotinib in the Treatment of Recurrent Craniopharyngioma

Phase 1/2 Recruiting

57 enrolled

CNS

Craniopharyngioma

NCT02162732 2025-11-03

Molecular-Guided Therapy for Childhood Cancer

Phase NA Completed

186 enrolled 12 charts

CNSGastrointestinalGenitourinarySarcoma

Carcinoma, Renal Cell, Craniopharyngioma, Ependymoma, Glioma, Carcinoma, Hepatocellular, Medulloblastoma, Meningioma, Neoplasms, Germ Cell and Embryonal, Wilms Tumor, Neuroblastoma, Rhabdomyosarcoma, Sarcoma, Ewing, Osteosarcoma, Choroid Plexus Neoplasms, Sarcoma, Clear Cell, Neuroectodermal Tumors, Primitive, Rhabdoid Tumor

NCT01419067 2025-10-20

A Phase II Trial of Limited Surgery and Proton Therapy for Craniopharyngioma or Observation After Radical Resection

Phase 2 Active not recruiting

112 enrolled

CNS

Craniopharyngioma

NCT07177482 2025-09-17

ImmunoPET Targeting Trophoblast Cell-surface Antigen 2 (Trop-2) in Craniopharyngioma Patients

Phase NA Recruiting

20 enrolled

CNS

Craniopharyngioma, Disease

NCT06299891 2025-07-28

Efficacy and Safety of Phentermine/Topiramate in Youth With Hypothalamic Obesity

Phase 2 Recruiting

24 enrolled

CNS

Craniopharyngioma, Hypothalamic Neoplasms, Sexual Infantilism

NCT04743310 2025-06-13

Fluorescence Detection of Adult Primary Central Nervous System Tumors With Tozuleristide and the Canvas System

Phase 2 Completed

50 enrolled

CNS

Astrocytoma, Brain Neoplasms, Craniopharyngioma, Ependymoma, Glioblastoma, Glioma, Medulloblastoma, Meningioma, Neoplasms, Germ Cell and Embryonal, Neuroma, Acoustic, Pinealoma, Spinal Cord Neoplasms, Central Nervous System Neoplasms